LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Article ; Online: Providing Office-Based Treatment of Opioid Use Disorder.

    Wilson, Courtenay Gilmore / Fagan, E Blake

    Annals of family medicine

    2017  Volume 15, Issue 5, Page(s) 481

    Language English
    Publishing date 2017-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2171425-3
    ISSN 1544-1717 ; 1544-1709
    ISSN (online) 1544-1717
    ISSN 1544-1709
    DOI 10.1370/afm.2139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Project ECHO

    Wilson, Courtenay Gilmore / Alexander, Susan / Hitch, William J / Lorenz-Miller, Lourdes / Vaughan, Ellis / Fagan, E Blake

    North Carolina medical journal

    2022  Volume 83, Issue 2, Page(s) 130–133

    Abstract: ... ...

    Abstract BACKGROUND
    MeSH term(s) COVID-19 ; Delivery of Health Care ; Humans ; Pandemics ; Primary Health Care ; SARS-CoV-2
    Language English
    Publishing date 2022-03-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 422795-5
    ISSN 0029-2559
    ISSN 0029-2559
    DOI 10.18043/ncm.83.2.130
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Factors demonstrating readiness for clinical pharmacy services.

    Wilson, Courtenay Gilmore / Ulrich, Irene Park / Scott, Mollie Ashe

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

    2019  Volume 76, Issue 21, Page(s) 1717–1718

    MeSH term(s) Humans ; Pharmacists ; Pharmacy Service, Hospital ; Primary Health Care
    Language English
    Publishing date 2019-10-17
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1224627-x
    ISSN 1535-2900 ; 1079-2082
    ISSN (online) 1535-2900
    ISSN 1079-2082
    DOI 10.1093/ajhp/zxz187
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder.

    Wilson, Courtenay Gilmore / Ramage, Melinda / Fagan, E Blake

    The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association

    2020  Volume 37, Issue 1, Page(s) 169–171

    MeSH term(s) Buprenorphine, Naloxone Drug Combination/therapeutic use ; COVID-19/epidemiology ; Humans ; Narcotic Antagonists/therapeutic use ; Opiate Substitution Treatment/methods ; Opioid-Related Disorders/drug therapy ; Pandemics ; Primary Health Care/organization & administration ; Rural Health Services/organization & administration ; SARS-CoV-2 ; Telemedicine/organization & administration ; United States/epidemiology
    Chemical Substances Buprenorphine, Naloxone Drug Combination ; Narcotic Antagonists
    Keywords covid19
    Language English
    Publishing date 2020-06-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 639160-6
    ISSN 1748-0361 ; 0890-765X
    ISSN (online) 1748-0361
    ISSN 0890-765X
    DOI 10.1111/jrh.12438
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.

    Ostrach, Bayla / Potter, Rachel / Wilson, Courtenay Gilmore / Carpenter, Delesha

    Journal of the American Pharmacists Association : JAPhA

    2021  Volume 62, Issue 2, Page(s) 588–597.e2

    Abstract: Background: Opioid-related drug overdoses have been rapidly increasing in the United States, especially in rural Southern and Appalachian regions. The use of buprenorphine-containing medications to treat opioid use disorder (OUD) is an evidence-based ... ...

    Abstract Background: Opioid-related drug overdoses have been rapidly increasing in the United States, especially in rural Southern and Appalachian regions. The use of buprenorphine-containing medications to treat opioid use disorder (OUD) is an evidence-based approach proven to reduce overdose death risks. Access to such treatment is uneven, with less access in parts of the United States where overdose rates are higher. Pharmacy dispensing of buprenorphine is a key component of access, yet barriers related to perceived and actual regulatory constraints, training gaps, stigma, and challenges to prescriber-pharmacist communication limit dispensing of this life-saving medication.
    Objectives: The objectives of this study were to explore the experiences of rural patients with OUD filling prescriptions for buprenorphine-containing medications at community pharmacies.
    Practice description: Rural community pharmacies, both commercial chain and independent, in 2 rural South-Central Appalachian counties where the local health departments prescribe buprenorphine-containing medications.
    Practice innovation: The local county health departments each entered into dedicated dispensing arrangements with a local independent community pharmacy to ensure a stable supply of medication for their patients with OUD who were prescribed buprenorphine.
    Evaluation methods: Qualitative interviews (n =16) with patients prescribed buprenorphine from their county health department; county health department staff, local harm reduction program staff, and harm reduction program participants prescribed buprenorphine. Transcripts were analyzed using thematic analysis.
    Results: Participants reported problems with buprenorphine dispensing at rural community pharmacies, dispensing delays that resulted in experiencing withdrawal symptoms and hesitation to continue in treatment, high medication costs, and stigmatizing treatment by some pharmacists. Participants also reported that access improved after dedicated dispensing arrangements began.
    Conclusion: Agreements between prescribing health departments and community pharmacies could increase access to buprenorphine, especially in rural areas.
    MeSH term(s) Buprenorphine ; Drug Overdose/drug therapy ; Drug Overdose/prevention & control ; Humans ; Naloxone/therapeutic use ; Opioid-Related Disorders/drug therapy ; Pharmacies ; Pharmacists ; United States
    Chemical Substances Naloxone (36B82AMQ7N) ; Buprenorphine (40D3SCR4GZ)
    Language English
    Publishing date 2021-10-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2118585-2
    ISSN 1544-3450 ; 1544-3191 ; 1086-5802
    ISSN (online) 1544-3450
    ISSN 1544-3191 ; 1086-5802
    DOI 10.1016/j.japh.2021.10.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A Primary Care Response to COVID‐19 for Patients with an Opioid Use Disorder

    Wilson, Courtenay Gilmore / Ramage, Melinda / Fagan, E. Blake

    The Journal of Rural Health ; ISSN 0890-765X 1748-0361

    2020  

    Keywords Public Health, Environmental and Occupational Health ; covid19
    Language English
    Publisher Wiley
    Publishing country us
    Document type Article ; Online
    DOI 10.1111/jrh.12438
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Allocating clinical ambulatory care pharmacy resources.

    Wilson, Courtenay Gilmore / Grandy, Rebecca

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

    2016  Volume 73, Issue 22, Page(s) 1815–1823

    MeSH term(s) Ambulatory Care/economics ; Ambulatory Care/trends ; Delivery of Health Care/trends ; Health Services Needs and Demand/economics ; Health Services Needs and Demand/trends ; Humans ; Pharmacy Service, Hospital/economics ; Pharmacy Service, Hospital/trends ; Resource Allocation/economics ; Resource Allocation/trends
    Language English
    Publishing date 2016-11-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1224627-x
    ISSN 1535-2900 ; 1079-2082
    ISSN (online) 1535-2900
    ISSN 1079-2082
    DOI 10.2146/ajhp160044
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Long-acting, Injectable Buprenorphine: Great Promise, but Significant Barriers to Use.

    Major, Erin / Fusco, Carriedelle Wilson / White, Zach / Wilson, Courtenay Gilmore / Fagan, E Blake

    North Carolina medical journal

    2020  Volume 81, Issue 3, Page(s) 210–211

    MeSH term(s) Buprenorphine/administration & dosage ; Buprenorphine/therapeutic use ; Delayed-Action Preparations ; Health Services Accessibility ; Humans ; Injections ; Treatment Outcome
    Chemical Substances Delayed-Action Preparations ; Buprenorphine (40D3SCR4GZ)
    Language English
    Publishing date 2020-05-04
    Publishing country United States
    Document type Letter
    ZDB-ID 422795-5
    ISSN 0029-2559
    ISSN 0029-2559
    DOI 10.18043/ncm.81.3.210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID‐19 pandemic

    Hughes, Phillip M. / Verrastro, Genevieve / Fusco, Carriedelle Wilson / Wilson, Courtenay Gilmore / Ostrach, Bayla

    Journal of rural health. 2021 June, v. 37, no. 3

    2021  

    Abstract: PURPOSE: Tracking changes in care utilization of medication for opioid use disorder (MOUD) services before, during, and after COVID‐19‐associated changes in policy and service delivery in a mixed rural and micropolitan setting. METHODS: Using a ... ...

    Abstract PURPOSE: Tracking changes in care utilization of medication for opioid use disorder (MOUD) services before, during, and after COVID‐19‐associated changes in policy and service delivery in a mixed rural and micropolitan setting. METHODS: Using a retrospective, open‐cohort design, we examined visit data of MOUD patients at a family medicine clinic across three identified periods: pre‐COVID, COVID transition, and COVID. Outcome measures include the number and type of visits (in‐person or telehealth), the number of new patients entering treatment, and the number of urine drug screens performed. Distance from patient residence to clinic was calculated to assess access to care in rural areas. Goodness‐of‐Fit Chi‐Square tests and ANOVAs were used to identify differences between time periods. FINDINGS: Total MOUD visits increased during COVID (436 pre vs. 581 post, p < 0.001), while overall new patient visits remained constant (33 pre vs. 29 post, p = 0.755). The clinic's overall catchment area increased in size, with new patients coming primarily from rural areas. Length of time between urine drug screens increased (21.1 days pre vs. 43.5 days post, p < 0.001). CONCLUSIONS: The patterns of MOUD care utilization during this period demonstrate the effectiveness of telehealth in this area. Policy changes allowing for MOUD to be delivered via telehealth, waiving the need for in‐person initiation of MOUD, and increased Medicaid compensation for MOUD may play a valuable role in improving access to MOUD during the COVID‐19 pandemic and beyond.
    Keywords COVID-19 infection ; drug therapy ; drugs ; issues and policy ; patients ; rural health ; telemedicine ; urine ; watersheds
    Language English
    Dates of publication 2021-06
    Size p. 467-472.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note JOURNAL ARTICLE
    ZDB-ID 639160-6
    ISSN 0890-765X
    ISSN 0890-765X
    DOI 10.1111/jrh.12570
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top